top of page

Search Results

Results found for "positive allosteric modulators"

  • Weekly News October 16 | Dr. GPCR Ecosystem

    Explore inhibition modes, CYP450 allostery, and insights from Dr. unpack inhibition modes (competitive, noncompetitive, mixed, uncompetitive), the messy truth of CYP450 allostery and DDIs, and why allosteric control can protect potency in substrate-rich environments.

  • Interrogating Multiscale Receptors Functions in Space

    Beaulieu received a Ph.D. in Neurological Sciences from McGill University and completed his post-doctoral The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling and explores the potential usefulness of beta-arrestins for the development Translational validation is important to validate findings obtained from experimental models research

  • Dr. Samuel Hoare | Dr. GPCR Ecosystem

    Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors

  • Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem

    Beaulieu received a Ph.D. in Neurological Sciences from McGill University and completed his post-doctoral The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling and explores the potential usefulness of beta-arrestins for the development Translational validation is important to validate findings obtained from experimental models research

  • Dr. GPCR Summit 2022 Live Talks Schedule

    12:00:00 GMT+0000 (Coordinated Universal Time) Details Fine-tuning glutamate receptor activity with allosteric modulators for neurodegenerative and psychiatric disorders Dr. Nicola Dijon Wed Oct 12 2022 17:40:00 GMT+0000 (Coordinated Universal Time) Details Functional modulation Stuart Maudsley Fri Oct 14 2022 16:00:00 GMT+0000 (Coordinated Universal Time) Details Biased Allosteric Modulators in Drug Discovery Dr.

  • irreversible drugs post 2 | Dr. GPCR Ecosystem

    Home → Flash News → irreversible drugs post 2 Persistent binding ≠ just covalent. And why slow-dissociating allosteric inhibitors can reshape signaling curves for hours — or even days kinetics as an afterthought, you’re already behind. ✳️ Read More: https://www.ecosystem.drgpcr.com/post

  • Dr. Terry Kenakin | Dr. GPCR Ecosystem

    Kenakin then moved to the UK, where he did a post-doctoral fellowship in University College London with His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr.

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology transition to become Dean and his decision to move from Australia to the United States for a postdoctoral position Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK and his experiences of meeting influential figures

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology transition to become Dean and his decision to move from Australia to the United States for a postdoctoral position Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK and his experiences of meeting influential figures

  • Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem

    Fellowship to develop novel methods of synthesizing 2 -imidazoline scaffolds to be used as proteasome modulators Lauren Slosky, she is working to understand the mechanism by which a new class of biased allosteric modulators

  • Dr. Roger Sunahara | Dr. GPCR Ecosystem

    Gilman, at the University of Texas Southwestern Medical School as a post-doctoral fellow. The structure was first snapshot of the agonist- and G protein-bound GPCR, providing valuable models We have identified several GPCR ligands that allosterically modulate orthosteric ligand binding and target

  • Dr. Patrick Sexton | Dr. GPCR Ecosystem

    He is a leader in the study of GPCRs, biased agonism, and also on allosteric interactions between GPCRs

  • Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem

    Alessandro Nicoli shares how he models olfactory GPCRs with AlphaFold, mentors students, and builds science Nicoli’s turning point came when he realized that molecules weren’t static—they could act , bind , and modulate “AlphaFold gave us a face to those proteins… now we have 400 models to start with.” – Alessandro Nicoli Build predictive models to discover new ligands . 8. water, membranes, ligands.” – Alessandro Nicoli He emphasized that MD allows researchers to observe allosteric

  • Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    The NRS fuses the extracellular region of any given aGPCR with a cleavage module from a Notch receptor Upon NTF dissociation, an intracellular transcription factor (reporter module) is released, generating The platform has been successfully used internally to identify biased small molecule negative allosteric modulators for protease-activated receptor 2 (PAR2). Sabbagh undertook post-doctoral fellowships at the Ontario Cancer Institute and the University of Toronto

  • Flash News: Your Hub for GPCR Insights and Scientific Conference Programs

    Through live Q&A, targeted modules, and short, focused lessons, Terry’s Corner gives discovery teams session, you’ll learn how to: Decode GPCR signaling complexity using functional assay strategies Identify allosteric modulators before they derail downstream decisions Integrate kinetics early—before your program locks Inside Terry’s Corner, you’ll gain access to focused, high-impact modules built for teams who need to And why slow-dissociating allosteric inhibitors can reshape signaling curves for hours — or even days

  • Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem

    20th World Congress of Basic and Clinical Pharmacology - Australia GPCR Jobs NEW Open Postdoctoral position and a PhD/post-doc level position - Eli Lilly and Company Postdoctoral Posit ion And PhD Position - affects larval growth and embryonic development in the multivoltine strain of Bombyx more Profiling Allosteric Modulators of CB1R with an Allosteric Fluoroprobe GPCRs in Cardiology, Endocrinology, and Taste Immunolocalization β-arrestin-1/endothelin axis in human ovarian fibroblasts Methods & Updates in GPCR Research Histamine-modulated

  • Dr. Michael Feigin | Dr. GPCR Ecosystem

    Next steps • Mike will consider using Twitter to post job positions in his lab. Career Trajectory and Faculty Position Yamina and Mike discussed Mike's career trajectory and his decision to pursue a faculty position. GPCRs and Cancer Immune Modulation Yamina and Mike had a discussion about their research on GPCRs, specifically They also touched upon the potential of GPCR modulation in stimulating the immune system to fight cancer

  • GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem

    There’s allosterism, receptor desensitization… it opened a whole new world.”

  • Translating computational approaches to GPCR biologists with Dr. Riccardo Capelli | Dr. GPCR Ecosystem

    He then held a postdoctoral position at Forschungszentrum Jülich (Germany), where he worked on calculating postdoctoral role at the Polytechnic University of Turin (Italy), where he developed coarse-grained models Now in a tenure-track position, his research spans the development of computational methods such as structure-based models and enhanced sampling techniques, as well as their application to biomolecular systems, mainly

  • Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem

    During these four sessions, you'll dive into: Advanced pharmacokinetic modeling The Druglike Quality ✅ Practical Quantification of Allosteric Modulation – May 1, 2025 ✅ Applying the Black/Leff Operational Model to Predict Agonism – October 2, 2025 Premium Members save 25% on enrollment. Structural Biologist Associate Director/Director, Platform & Hit-ID Chemistry Lead Junior associate position and a PhD/post-doc level position Postdoctoral Position And PhD Position GPCR Molecular Pharmacologist

  • Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    CD97 in glioblastoma Dimitris Placantonakis Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation out Ryk, required for Vangl2 function, protected synapses and preserved cognitive function in a mouse model Collectively, these data suggest that ADCs targeting CD97 impair tumor growth in preclinical GBM models Placantonakis Lab Google Scholar LinkedIn Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation I then pursued a postdoctoral research position under the mentorship of Dr. Jonathan A.

  • Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Domain in a Holo-Adhesion GPCR Demet Araç Abstract "According to the Tethered Agonist (TA)-mediated model in which the conformation of the Extracellular Region (ECR) has a direct role in modulating the 7TM The TA peptide remains at its original position and is not involved in signaling. We utilize several genetically modified mouse models to investigate requirements for receptor activator and continuously work to identify novel chemical modulators of AGPCRs through assay development and

  • Dr. Richard Premont | Dr. GPCR Ecosystem

    In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert In 1999, obtained an independent faculty position at Duke in Gastroenterology, where he remained until complexes during cellular signaling, and characterizing the role of protein S-nitrosylation as a signaling post-translational including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior

  • Dr. Richard Premont | Dr. GPCR Ecosystem

    In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert In 1999, obtained an independent faculty position at Duke in Gastroenterology, where he remained until complexes during cellular signaling, and characterizing the role of protein S-nitrosylation as a signaling post-translational including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior

  • Dr. Richard Premont | Dr. GPCR Ecosystem

    In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert In 1999, obtained an independent faculty position at Duke in Gastroenterology, where he remained until complexes during cellular signaling, and characterizing the role of protein S-nitrosylation as a signaling post-translational including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior

  • Dr. Richard Premont | Dr. GPCR Ecosystem

    In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert In 1999, obtained an independent faculty position at Duke in Gastroenterology, where he remained until complexes during cellular signaling, and characterizing the role of protein S-nitrosylation as a signaling post-translational including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior

  • Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem

    Can models predict drug outcomes? Jens Carlsson shares how GPCR modeling is moving from explanation to real prediction in drug discovery . << Back to podcast list Strategic Partner(s) Model. Yamina Berchiche to share his unconventional journey from aspiring engineer to GPCR modeler. His team focuses on understanding how ligands modulate receptor function and how those insights can drive

  • Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Receptors Fabian Pohl Structural studies of the CELSR1 extracellular region reveal a compact multidomain module This compact module provides a plethora of potential ligand binding sites for the various adhesion domains within the structure and hints at a model where the compact module could be pulled apart by robust mechanical We assign the N-terminal CADH1-8 module as necessary for cell adhesion and we show the C-terminal CAHD9 -GAIN module regulates signaling.

  • Ecosystem Contributor | Dr. GPCR Ecosystem

    Discover how you can make a positive impact on the field and inspire others to do the same.

  • Partners Submition Form | Dr. GPCR Ecosystem

    GPCR Ecosystem and collaborate with us to make a positive impact.

bottom of page